Dergiler / Acta Medica / 2022 / Cilt: 53 - Sayı: 3

Bioinformatic Analysis of Expression Pattern and Prognostic Value of Oxidoreductase ERO1L in Pancreatic Cancer

Sayfa
233–244
Yayın Tarihi
2022-11-11
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: Oxidoreductase ERO1L is a potential prognostic marker and its oncogenic effects might be regulated via hypoxia/ER stress/ERO1L/ VEGFA axis in pancreatic cancer.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: As people continue to succumb to the progression of various forms of cancer, the extreme lethal nature of pancreatic cancer in particular suggests that new therapeutic targets and novel regulatory mechanisms need to be explored.
📊
Temel Bulgular & Veri:Materials and Methods: We examined ERO1L expression in different cancer types using cBioPortal and Oncomine exploration tools.
💡
Sonuç & Katkı:Conclusion: Oxidoreductase ERO1L is a potential prognostic marker and its oncogenic effects might be regulated via hypoxia/ER stress/ERO1L/ VEGFA axis in pancreatic cancer.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: As people continue to succumb to the progression of various forms of cancer, the extreme lethal nature of pancreatic cancer in particular suggests that new therapeutic targets and novel regulatory mechanisms need to be explored. Materials and Methods: We examined ERO1L expression in different cancer types using cBioPortal and Oncomine exploration tools. Next, we analyzed ERO1L levels in pancreatic cancer and healthy tissues via online public databases. The prognostic value of ERO1L and its correlation with clinopathological features were investigated using the UCSC, TNMplot and cBioPortal databases. The correlation analyses were then performed using data obtained from GEPIA, cBioPortal and the Gene Expression Omnibus. Results: The enzyme ERO1L was found to be highly expressed in pancreatic cancer and elevated in tumor compared to healthy tissue. Its levels correlated with the hypoxia level and ER stress activation status of the pancreatic cancer tissues. ERO1L and VEGFA levels were also found to be correlated exclusively in tumor tissue, thus underlying its pro-oncogenic nature. Conclusion: Oxidoreductase ERO1L is a potential prognostic marker and its oncogenic effects might be regulated via hypoxia/ER stress/ERO1L/ VEGFA axis in pancreatic cancer.

🔖

Bu Makaleye Atıf Yap

KOCATÜRK, B. (2022). Bioinformatic Analysis of Expression Pattern and Prognostic Value of Oxidoreductase ERO1L in Pancreatic Cancer. Acta Medica, Cilt: 53 - Sayı: 3, 233–244. https://ajindex.com/articles/654098

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Sung, H, Ferlay, J, Siegel, RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3): 209-249
  2. Siegel, RL, Miller, KD, Jemal, A Cancer statistics, 2020. CA Cancer J Clin. 2020; 70(1): 7-30
  3. Strobel, O, Neoptolemos, J, Jager, D, et al. Optimizing the outcomes of pancreatic cancer surgery. Nat Rev Clin Oncol. 2019; 16(1): 11-26
  4. Feige, MJ, Hendershot, LM Disulfide bonds in ER protein folding and homeostasis. Curr Opin Cell Biol. 2011; 23(2): 167-175
  5. Benham, AM, van, LM, Sitia, R, et al. Ero1-PDI interactions, the response to redox flux and the implications for disulfide bond formation in the mammalian endoplasmic reticulum. Philos Trans R Soc Lond B Biol Sci. 2013; 368(1617): 20110403
  6. Gess, B, Hofbauer, KH, Wenger, RH, et al. The cellular oxygen tension regulates expression of the endoplasmic oxidoreductase ERO1-Lalpha. Eur J Biochem. 2003; 270(10): 2228-2235
  7. Pagani, M, Fabbri, M, Benedetti, C, et al. Endoplasmic reticulum oxidoreductin 1-lbeta (ERO1-Lbeta), a human gene induced in the course of the unfolded protein response. J Biol Chem. 2000; 275(31): 23685-23692
  8. Zhang, J, Yang, J, Lin, C, et al. Endoplasmic Reticulum stress-dependent expression of ERO1L promotes aerobic glycolysis in Pancreatic Cancer. Theranostics. 2020; 10(18): 8400-8414
  9. Kutomi, G, Tamura, Y, Tanaka, T, et al. Human endoplasmic reticulum oxidoreductin 1-alpha is a novel predictor for poor prognosis of breast cancer. Cancer Sci. 2013; 104(8): 1091-1096
  10. Seol, SY, Kim, C, Lim, JY, et al. Overexpression of Endoplasmic Reticulum Oxidoreductin 1-alpha (ERO1L) Is Associated with Poor Prognosis of Gastric Cancer. Cancer Res Treat. 2016; 48(4): 1196-1209
  11. Yang, S, Yang, C, Yu, F, et al. Endoplasmic reticulum resident oxidase ERO1-Lalpha promotes hepatocellular carcinoma metastasis and angiogenesis through the S1PR1/STAT3/ VEGF-A pathway. Cell Death Dis. 2018; 9(11): 1105 [12] Tanaka, T, Kutomi, G, Kajiwara, T, et al. Cancer-associated oxidoreductase ERO1-alpha drives the production of VEGF via oxidative protein folding and regulating the mRNA level. Br J Cancer. 2016; 114(11): 1227-1234
  12. Varone, E, Decio, A, Chernorudskiy, A, et al. The ER stress response mediator ERO1 triggers cancer metastasis by favoring the angiogenic switch in hypoxic conditions. Oncogene. 2021; 40(9): 1721-1736
  13. Hidalgo, M Pancreatic cancer. N Engl J Med. 2010